Changes in Antidepressant Absorption After Metabolic Bariatric Surgery - Takeaways - MDSpire

Changes in Antidepressant Absorption After Metabolic Bariatric Surgery

  • By

  • Lucas Sabatella

  • Azucena Aldaz Pastor

  • Manuel Fortún Landecho Acha

  • Rafael Moncada Durruti

  • Daniel Aliseda Jover

  • Nuria Blanco Asensio

  • Victor Valentí Azcárate

  • July 4, 2025

  • 0 min

Share

  • 1

    Metabolic bariatric surgery, particularly RYGB, is the most effective long-term intervention for obesity but raises concerns about drug absorption.

  • 2

    Patients with obesity often have mood disorders, complicating the management of antidepressant medications post-surgery.

  • 3

    The study aimed to investigate pharmacokinetic changes in antidepressant levels in patients after undergoing RYGB.

  • 4

    Fourteen patients were analyzed, with significant weight loss observed between pre-surgery and post-surgery measurements.

  • 5

    The study highlights the need for more pharmacokinetic data to ensure effective and safe antidepressant treatment after bariatric surgery.

Original Source(s)

Changes in Antidepressant Absorption After Metabolic Bariatric Surgery

  • by Lucas Sabatella, Azucena Aldaz Pastor, Manuel Fortún Landecho Acha, Rafael Moncada Durruti, Daniel Aliseda Jover, Nuria Blanco Asensio, Victor Valentí Azcárate

  • July 4, 2025

Related Content

Correction to: Bariatric Surgery for Patients Living with Obesity and Left Ventricular Dysfunction: Evaluating Perioperative Safety and Postoperative Functional Outcomes

Visceral fat area and blood lipids in colorectal cancer: predictors of surgical risk and prognosis

Fluoroscopic parameters in the diagnosis and quantitative assessment of gastric sleeve stenosis